AEterna Zentaris (AEZS) Scientific Article Supports Perifosine's Development in Kidney Cancer 11/9/2009
More...
|
Antigenics Inc. (Lexington, MA) (AGEN) Kidney Cancer Vaccine Oncophage Rejected In Europe 10/21/2009
More...
|
FDA Approves GlaxoSmithKline (GSK)'s VOTRIENT(TM) for Advanced Renal Cell Cancer 10/20/2009
More...
|
Bayer Corporation (BAY) (JOBS), Onyx Pharmaceuticals, Inc. (ONXX)'s Contested Kidney Cancer Drug Shows Benefit 9/23/2009
More...
|
FDA Approves Roche (RHHBY) (JOBS), Genentech, Inc. (DNA)'s (JOBS) Avastin for the Most Common Type of Kidney Cancer 8/3/2009
More...
|
AEterna Zentaris (AEZS) Partner Keryx Biopharmaceuticals (KERX) Reports Positive Phase 2 Data for Perifosine (KRX-0401) in Colon and Kidney Cancer 6/1/2009
More...
|
AEterna Zentaris (AEZS) Partner Keryx Biopharmaceuticals (KERX) Reports Positive Phase 2 Data for Perifosine (KRX-0401) in Colon and Kidney Cancer at American Society of Clinical Oncology Meeting 6/1/2009
More...
|
Chronic Kidney Disease May Raise Cancer Risk, Westmead Hospital Study 5/11/2009
More...
|
Robotic Assisted Kidney Cancer Surgery Proves to be Beneficial to Patients, Fox Chase Cancer Center Study 4/29/2009
More...
|
Pfizer Inc. (PFE) (JOBS) Cancer Drug Gets Nod In UK Recommendation 2/4/2009
More...
|
Lorus Therapeutics Inc. (LRP) Publishes Study Demonstrating LOR-2040 Improves Anticancer Effects of Interferon in Kidney Cancer 1/28/2009
More...
|
No Association Found Between Fat, Protein, And Meat Consumption And Kidney Cancer, Brigham and Women's Hospital And Harvard Medical School Study 12/9/2008
More...
|
Genes Associated With Fat Metabolism Could Increase Kidney Cancer Risk, National Cancer Institute Study 11/25/2008
More...
|
Van Andel Institute Researchers Find That “Sticky” Chromosomes Have Role In Kidney Cancer 10/28/2008
More...
|
Freezing Kills Off Kidney Tumours, Southmead Hospital Reports 10/22/2008
More...
|
Antigenics Inc. (New York) (AGEN) Submits Oncophage(R) Application for European Approval 10/22/2008
More...
|
Drug Sorafenib Improves Kidney Cancer Outcomes, Addenbrooke's Hospital And University of Cambridge Study 10/10/2008
More...
|
Idera Pharmaceuticals, Inc. (IDRA) Drug IMO-2055 Disappoints as Kidney Cancer Treatment 10/1/2008
More...
|
Novartis AG (JOBS) Cancer Drug Wins U.S. Priority Review 9/9/2008
More...
|
NewYork-Presbyterian/Columbia Leads Research Into Robotic Surgery for Kidney Cancer 8/11/2008
More...
|
Pfizer Inc. (PFE), Roche Holding AG (RHHBF.PK) (JOBS), Bayer AG (BAY), and Wyeth (WYE) Cancer Drugs Rejected by U.K. Agency on Cost 8/8/2008
More...
|
2 New Genes Tied To 3 Cancers; Finding Could Improve Early Detection Of Breast, Thyroid And Kidney Diseases, Cleveland Clinic Researchers Say 8/8/2008
More...
|
Robotic Surgery at Columbia-Presbyterian Medical Center Provides Reduced Pain and Quicker Recovery for Kidney Cancer Patients 7/29/2008
More...
|
Sanofi-Aventis (France) (SASY.PA), Oxford BioMedica PLC (OXB.L) Say Cancer Drug Won't Meet Study Goal 7/11/2008
More...
|
Molecule Uses Cellular Recycling to Treat Kidney Cancer, Stanford University Study 7/8/2008
More...
|
Kidney Cancer Vaccine Shows No Boost in Survival in M. D. Anderson Cancer Center Study 7/7/2008
More...
|
Stanford University School of Medicine Researchers Find Molecule that Kills Kidney Cancer Cells 7/7/2008
More...
|
Wyeth Pharmaceuticals (Pennsylvania) (WYE) Initiates INTORACT -- A New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced Kidney Cancer 6/4/2008
More...
|
Wyeth Pharmaceuticals (Pennsylvania) (WYE) Release: New Analyses Presented at American Society of Clinical Oncology Reaffirmed Efficacy and Safety of TORISEL in Patients With Advanced Kidney Cancer - Data Showed Overall Survival Benefit With TORISEL Regardless of Nephrectomy Status; Additional Analysis Examined Specific Side Effects 6/2/2008
More...
|
Wyeth (WYE) Initiates INTORACT, a New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced Kidney Cancer 5/30/2008
More...
|
Sorafenib Shows Promise For Heart-Lung Disease; Cancer Drug Interferes With Abnormal Cell Growth Seen In Pulmonary Hypertension, University of Chicago Study 5/21/2008
More...
|
Novartis Pharmaceuticals Corporation (NVS) RAD001 More Than Doubles Time Without Tumor Growth After Failure of Standard Treatment in Patients With Advanced Kidney Cancer 5/19/2008
More...
|
Pfizer Japan Inc. Receives Manufacturing and Marketing Authorization for SUTENT 4/21/2008
More...
|
Antigenics Inc. (New York) (AGEN)'s Oncophage(R) Approved in Russia for the Treatment of Intermediate-Risk Kidney Cancer
4/8/2008
More...
|
St. Jude Children's Research Hospital Study Offers New Hope for Children With Kidney Tumors Deemed Inoperable 3/25/2008
More...
|
Antigenics Inc. (New York) (AGEN) to Present Phase 3 Oncophage(R) (vitespen) Data in Kidney Cancer at European Association of Urology Annual Congress 3/21/2008
More...
|
Novartis Pharmaceuticals Corporation (NVS)'s Everolimus (RAD001) Significantly Extends Progression-Free Survival in Advanced Kidney Cancer Patients After Failure of Other Targeted Therapy 2/28/2008
More...
|
Novartis AG Release: Everolimus (RAD001) Significantly Extends Progression-Free Survival in Advanced Kidney Cancer Patients After Failure of Other Targeted Therapy 2/28/2008
More...
|
Wyeth (WYE) Release: New Breakthrough Treatment for Advanced Kidney Cancer Shows 49 Per Cent Higher Survival Rates 2/20/2008
More...
|
Pfizer Inc. (PFE)'s Sutent Causes Heart Failure in Some Study Finds 2/13/2008
More...
|
Kidney Cancer Drug Attacks A Major Type Of Acute Myeloid Leukemia 1/30/2008
More...
|
Bayer Corporation (BAY) Gets Japan Approval for Kidney Cancer Drug 1/28/2008
More...
|
Cardiff University: Genetic Breakthrough Offers Promise In Tackling Kidney Tumors 1/10/2008
More...
|
Coffee, Tea Linked to Lower Risk of Kidney Cancer 12/26/2007
More...
|
Wyeth (WYE)'s TORISEL Receives European Commission Approval for the Treatment of Advanced Kidney Cancer TORISEL Extends Median Overall Survival vs. Interferon-Alpha 11/27/2007
More...
|
Cryoablation Continues to Show Good Results for Kidney Cancer Patients, Mayo Clinic Study Shows 11/26/2007
More...
|
Cleveland Biolabs Inc. (CBLI) Launches Phase II Advanced Renal Cell Carcinoma Trial for Curaxin CBLC102 11/26/2007
More...
|
Keryx Biopharmaceuticals (KERX) Phase 1 & 2 Data of Perifosine (KRX-0401) in Patients with Advanced Renal Cell Carcinoma Presented Today 11/9/2007
More...
|
Pfizer Inc. (PFE)'s Axitinib Shows Promise in Kidney Cancer 10/31/2007
More...
|
Experimental Drug Shows Promise in Advanced Kidney Cancer 9/26/2007
More...
|
Alcohol May Lower Risk of Kidney Cancer 8/27/2007
More...
|
Reactivating a Critical Gene Lost in Kidney Cancer Reduces Tumor Growth, Mayo Clinic Study 8/16/2007
More...
|
Antigenics Inc. (New York) (AGEN) Provides Update on Filing for Approval of Oncophage(R) in Russia for the Treatment of Intermediate-Risk Kidney Cancer 8/2/2007
More...
|
New Two-Drug Kidney Cancer Treatment Found by Duke University Researchers 8/1/2007
More...
|
Wake Forest University Baptist Medical Center Study Shows Radiofrequency Ablation Highly Effective in Treating Kidney Tumors 8/1/2007
More...
|
Radio Frequency Ablation Vaporizes Inoperable Kidney And Liver Tumors 6/29/2007
More...
|
Genentech, Inc. (DNA)'s Phase III Study Shows Avastin Plus Interferon Therapy Nearly Doubled Median Progression-Free Survival in Patients With Previously Untreated Advanced Kidney Cancer 6/4/2007
More...
|
Wyeth (WYE) Data Presented at American Society of Clinical Oncology Showed TORISEL Significantly Increased Quality-Adjusted Survival for Patients With Advanced Renal Cell Carcinoma 6/4/2007
More...
|
Pfizer Inc. (PFE): Single-Agent SUTENT Prolonged Progression-Free Survival across All Advanced Kidney Cancer Patient Risk Groups, Including Those with Poorest Prognoses, Data Show 6/4/2007
More...
|
FDA Approves Wyeth (WYE)'s (Jobs) TORISEL, a Targeted First-in-Class mTOR Inhibitor for the Treatment of Advanced Kidney Cancer 5/31/2007
More...
|
Antigenics Inc. (New York) (AGEN)'s Oncophage(R) Cancer Vaccine Significantly Prolongs Recurrence-Free Survival by 45 Percent in Patients With Intermediate-Risk Kidney Cancer 5/21/2007
More...
|
Cryoablation -- A New Treatment Option for Some Kidney Tumor Patients, Mayo Clinic Researchers Find 3/29/2007
More...
|
Misonix Incorporated (MSON) Announces First Successful HIFU Procedures for Human Kidney Cancer 3/22/2007
More...
|
Misonix Incorporated (MSON) Spotlights HIFU Medical Devices for Prostate and Kidney Cancer Treatment at European Association of Urology Conference 2007 3/20/2007
More...
|
A New Pharmaceutical Drug that Halts Progress of Metastatic Kidney Cancer 3/2/2007
More...
|
Bayer Corporation (BAY) And Onyx Pharmaceuticals, Inc. (ONXX) Announce Pivotal Nexavar(R) Kidney Cancer Study Published In The New England Journal of Medicine 1/11/2007
More...
|
Vaccine "Tackles Kidney Cancer" 11/13/2006
More...
|
White Bread Increases Kidney Cancer Risk 10/20/2006
More...
|
Pre-Op Chemotherapy Aids Young Cancer Patients 10/10/2006
More...
|
Synthetic Molecule Causes Cancer Cells To Self-Destruct 8/28/2006
More...
|
Argos Therapeutics, Inc. Initiates Phase I/II Trial With AGS-003 Personalized Immunotherapy In Advanced Kidney Cancer; Trial To Evaluate New Production Process That May Yield More Potent Immune Response 8/17/2006
More...
|
Endocare, Inc. (ENDO) Release: Cryoablation Studies Published In July Supplement To Journal UROLOGY Demonstrate Effectiveness Of Treatment For Kidney Cancer 7/26/2006
More...
|
Bayer Pharmaceuticals Corporation (CT) And Onyx Pharmaceuticals, Inc. (ONXX) Release: Nexavar(R) Approved By European Commission For The Treatment Of Advanced Kidney Cancer 7/24/2006
More...
|
Mayo Clinic Researchers Discover Immune System Blocker At Work In Kidney Cancer 6/30/2006
More...
|
Keryx Biopharmaceuticals (KERX) Announces Positive Final Results From Phase 2 Dose-Ranging Study Of Zerenex(TM) For The Treatment Of Hyperphosphatemia In Patients With End-Stage Renal Disease 6/29/2006
More...
|
Mayo Clinic Researchers Discover Immune System Blocker At Work In Kidney Cancer 6/29/2006
More...
|
Feds Warn San Francisco Kaiser Permanente 6/8/2006
More...
|
Antigenics Inc. (New York) (AGEN) Announces Results From In-Depth Analysis Of Phase 3 Data Of Oncophage In Kidney Cancer And Provides Regulatory Update 6/7/2006
More...
|
Bayer Pharmaceuticals Corporation (CT) And Onyx Pharmaceuticals, Inc. (ONXX) Kidney Cancer Drug Nexavar Misses Survival Goal In Trial 6/5/2006
More...
|
More Than 100 Studies From Pfizer Inc. (PFE)'s Extensive Oncology Portfolio To Be Presented At American Society of Clinical Oncology 2006 6/2/2006
More...
|
Bayer Pharmaceuticals Corporation (CT) And Onyx Pharmaceuticals, Inc. (ONXX) Release: Nexavar Approved In Switzerland For The Treatment Of Patients With Advanced Kidney Cancer 3/30/2006
More...
|
Antigenics Inc. (New York) (AGEN) Reports Phase 3 Results For Oncophage In Kidney Cancer; Study Did Not Meet Endpoints; Stock Plunges 3/24/2006
More...
|
Pfizer Inc. (PFE)'s Cancer Therapy SUTENT(R) Receives FDA Approval 1/27/2006
More...
|
Scientists Uncover Mechanism Of Response To Targeted Therapy In Kidney Cancer 1/12/2006
More...
|
Moderate Drinking May Lower Kidney Cancer Risk 12/29/2005
More...
|
Bayer Pharmaceuticals Corporation (CT) And Onyx Pharmaceuticals, Inc. (ONXX) Release: FDA Approves Nexavar(R) For Treatment Of Patients With Advanced Kidney Cancer 12/20/2005
More...
|
Antigenics Inc. (New York) (AGEN) Updates Business Strategy, Outlines Timeline For The Analysis Of Its Phase 3 Kidney Cancer Trial; 81 Jobs Cut 12/7/2005
More...
|
Shire Pharmaceuticals (SHPGY)'s New Higher Dose Formulation Of FOSRENOL(R) Approved To Reduce Serum Phosphorus In End-Stage Renal Disease Patients 11/28/2005
More...
|
Bayer Corporation (BAY) Says Kidney Cancer Drug Prolongs Life 11/3/2005
More...
|
Bayer Corporation (BAY) And Onyx Pharmaceuticals, Inc. (ONXX) Announce Nexavar(R) Tablets As Global Trade Name For Investigational Cancer Treatment 10/28/2005
More...
|
Genentech, Inc. (DNA) Says Tarceva Doesn't Boost Avastin Effect 10/18/2005
More...
|
Genzyme Corporation (GENZ) Release: Renagel Study In New Dialysis Patients Published In Kidney International 9/29/2005
More...
|
Laserscope's (LSCP) Greenlight PV(R) Laser System Shows Potential For Treating Kidney Tumors 9/20/2005
More...
|
Bayer Pharmaceuticals Corporation (CT) And Onyx Pharmaceuticals, Inc. (ONXX) Announce European Marketing Submission For Sorafenib 9/12/2005
More...
|
Antisoma PLC (ASM.L) Granted U.S. Orphan Drug Status For AS1411 In Renal Cancer 8/18/2005
More...
|
Pfizer Inc. (PFE) To File For Sutent Drug In August 7/21/2005
More...
|
Bayer Pharmaceuticals Corporation (CT) And Onyx Pharmaceuticals, Inc. (ONXX) Complete Filing Of New Drug Application For Sorafenib For Individuals With Advanced Renal Cell Carcinoma 7/11/2005
More...
|
OncoMethylome Sciences S.A. Announces Licensing Agreement With Fox Chase Cancer Center For The Early Detection Of Ovarian And Kidney Cancers 6/22/2005
More...
|
Avantogen Limited Receives Milestone Payment From Endocyte For GPI Vaccine Adjuvant; Company Also Receives European Patent And Commences Preclinical Studies For Herpes Vaccine 6/15/2005
More...
|
GenoMed, Inc. To Be Awarded Second Patent, For Treating Acute Kidney Failure Without Dialysis 6/14/2005
More...
|
Affymax, Inc. Presents Hematide Clinical Results Demonstrating Potent Effect On Red Blood Cell Production 6/8/2005
More...
|
Antigenics Inc. (New York)' (AGEN) Oncophage Cancer Vaccine Receives European Orphan Drug Designation For Renal Cell Carcinoma 6/7/2005
More...
|
Vivant Medical Announces The Presentation Of Clinical Study Data On The Microwave Ablation Of Renal Tumors At The American Urological Association's Annual Meeting 5/18/2005
More...
|
Bayer Pharmaceuticals Corporation And Onyx Pharmaceuticals, Inc. (ONXX) Sorafenib (BAY 43-9006) Doubles Progression-Free Survival In Phase III Kidney Cancer Trial 5/16/2005
More...
|
Isotechnika Inc. (ISA.TO) Granted Permission From FDA For Phase IIb Kidney Transplant Trial 5/12/2005
More...
|
Swiss Biotech Speedel Pharma AG Pulls IPO Due To Market Conditions 5/11/2005
More...
|
Nephrogenix Pty Ltd Licenses Molecular Profiling Technology And Kinase Inhibitors For Kidney Disease 5/6/2005
More...
|
Bayer Pharmaceuticals Corporation (CT) And Onyx Pharmaceuticals, Inc. (ONXX) Unblind Patients In Ongoing Sorafenib Phase III Clinical Trial in Advanced Renal Cell Carcinoma 4/18/2005
More...
|
Lorus Therapeutics Inc. (LRP) Successfully Completes Phase II Study Of GTI-2040 Combination Therapy For Treatment Of Kidney Cancer 4/12/2005
More...
|
Renal Solutions Completes $16.5 Million Series B Financing And Will Present At The SG Cowen & Co., LLC Health Care Conference 3/8/2005
More...
|
Nabi Biopharmaceuticals (NABI) Files For European Regulatory Approval For StaphVAX(R) To Prevent S. Aureus Infections In End-Stage Renal Disease Patients 12/21/2004
More...
|
Vivant Medical And Wake Forest University Baptist Medical Center Announce Completion Of An Ablate And Resect Study Of Renal Tumors 11/10/2004
More...
|
Onyx Pharmaceuticals (ONXX) And Bayer Pharmaceuticals Corporation (CT): Mixed Phase II Clinical Trial Results For Advanced Kidney Cancer Drug BAY 43-9006; ONXX Shares Tumble After Cancer Drug Filing Delay 10/25/2004
More...
|
Positive Clinical Results Observed In Lorus Therapeutics Inc.'s (LORFF) Clinical Trial Of GTI-2040 8/13/2004
More...
|
Bayer AG (BAY) Cancer Drug Gets EU Orphan Drug Status 8/4/2004
More...
|
Accuray Launches World's First Dynamic Radiosurgery System For Lung, Liver, Kidney And Pancreatic Tumors 7/19/2004
More...
|
Study Identifies Promising Treatment For Kidney Cancers 7/1/2004
More...
|
MERIX Bioscience, Inc. Launches Trial For New Kidney Cancer Vaccine 6/8/2004
More...
|
Bayer Pharmaceuticals Corporation (CT) Release: Encouraging Interim Results On BAY 43-9006 In Advanced Kidney Cancer Presented At American Society of Clinical Oncology Meeting 6/7/2004
More...
|
Bevacizumab Plus Erlotinib Highly Active In Advanced Kidney Cancer 6/7/2004
More...
|
ASCO Drugs To Watch 6/4/2004
More...
|
Fox Chase Cancer Center Research Shows Kidney Cancer Can Be Diagnosed In Urine 5/10/2004
More...
|
Oxford BioMedica PLC (LS:OXB) Gains FDA Approval For A Phase II Trial Of Trovax® In Renal Cancer 4/29/2004
More...
|
Bayer Pharmaceuticals Corporation (CT) And Onyx Pharmaceuticals (ONXX) Release: BAY 43-9006 Receives Fast Track Designation From The FDA For Metastatic Kidney Cancer Review 4/6/2004
More...
|
Marshall Edwards, Inc. (NVGN) Commences Renal Cancer Human Trial Of Phenoxodiol In Combination Therapy 3/8/2004
More...
|
Ariad Pharmaceuticals, Inc. (ARIA) Discovers New And Broader Potential Cancer Indications For Its Oncology Product Candidate, AP23464 2/24/2004
More...
|
Kidney Cancer Vaccine Shows Promise In Trial 2/20/2004
More...
|
Exelixis, Inc. (EXEL) Showcases R&D Pipeline At JPMorgan Healthcare Conference 1/13/2004
More...
|
Lorus Therapeutics Inc. (LORFF) Announces Interim Clinical Results Of GTI-2040 In Combination Chemotherapy For The Treatment Of Renal Cell Cancer 1/12/2004
More...
|
Oxford BioMedica PLC (LS:OXB) Oncology Update 12/18/2003
More...
|
Positive Results Confirmed In Final Report For Active Biotech's TTS Cancer Product 12/17/2003
More...
|
Urine Test May Find Early Kidney Cancer 12/16/2003
More...
|